Crossmark Global Holdings, Inc. Johnson & Johnson Transaction History

Crossmark Global Holdings, Inc.

$5.61 Billion
Q3 2024

A detailed history of Crossmark Global Holdings, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Crossmark Global Holdings, Inc. holds 38,719 shares of JNJ stock, worth $6 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

38,719

Previous 40,603 4.64%

Holding current value

$6 Million

Previous $5.93 Million 5.75%

% of portfolio

0.11%

Previous 0.11%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$145.48 - $167.38 $274,084 - $315,343	-1,884 Reduced 4.64%	38,719 $6.28 Million
Q2 2024 Jul 29, 2024	BUY	$144.38 - $157.78 $116,514 - $127,328	807 Added 2.03%	40,603 $5.93 Million
Q1 2024 May 13, 2024	SELL	$155.22 - $162.74 $228,328 - $239,390	-1,471 Reduced 3.56%	39,796 $6.3 Million
Q4 2023 Feb 13, 2024	SELL	$145.6 - $158.88 $79,788 - $87,066	-548 Reduced 1.31%	41,267 $6.47 Million
Q3 2023 Nov 08, 2023	SELL	$155.75 - $174.48 $509,614 - $570,898	-3,272 Reduced 7.26%	41,815 $6.62 Million
Q2 2023 Jul 31, 2023	BUY	$154.35 - $166.11 $411,342 - $442,683	2,665 Added 6.28%	45,087 $7.87 Million
Q1 2023 May 12, 2023	SELL	$151.05 - $180.26 $973,366 - $1.16 Million	-6,444 Reduced 13.19%	42,422 $6.58 Million
Q4 2022 Jan 19, 2023	SELL	$160.2 - $179.79 $214,828 - $241,098	-1,341 Reduced 2.67%	48,866 $8.63 Million
Q3 2022 Nov 01, 2022	BUY	$161.33 - $179.52 $301,203 - $335,163	1,867 Added 3.86%	50,207 $8.2 Million
Q2 2022 Jul 29, 2022	SELL	$168.19 - $186.01 $208,051 - $230,094	-1,237 Reduced 2.5%	48,340 $8.58 Million
Q1 2022 May 11, 2022	SELL	$158.14 - $179.59 $123,507 - $140,259	-781 Reduced 1.55%	49,577 $8.79 Million
Q4 2021 Jan 10, 2022	SELL	$155.93 - $173.01 $170,275 - $188,926	-1,092 Reduced 2.12%	50,358 $8.62 Million
Q3 2021 Oct 21, 2021	BUY	$161.5 - $179.47 $3.55 Million - $3.95 Million	21,995 Added 74.67%	51,450 $8.31 Million
Q3 2021 Oct 13, 2021	SELL	$161.5 - $179.47 $3.25 Million - $3.61 Million	-20,110 Reduced 40.57%	29,455 $2.03 Million
Q2 2021 Jul 21, 2021	SELL	$159.48 - $171.07 $1.11 Million - $1.19 Million	-6,967 Reduced 12.32%	49,565 $8.17 Million
Q1 2021 Apr 15, 2021	BUY	$153.07 - $170.48 $158,733 - $176,787	1,037 Added 1.87%	56,532 $9.29 Million
Q4 2020 Jan 14, 2021	SELL	$137.11 - $157.38 $207,995 - $238,745	-1,517 Reduced 2.66%	55,495 $8.73 Million
Q3 2020 Oct 08, 2020	SELL	$140.38 - $153.83 $260,826 - $285,816	-1,858 Reduced 3.16%	57,012 $8.49 Million
Q2 2020 Aug 14, 2020	BUY	$128.81 - $155.51 $130,098 - $157,065	1,010 Added 1.75%	58,870 $8.28 Million
Q1 2020 Apr 28, 2020	SELL	$111.14 - $153.99 $120,809 - $167,387	-1,087 Reduced 1.84%	57,860 $7.59 Million
Q4 2019 Feb 06, 2020	SELL	$127.5 - $146.44 $36,210 - $41,588	-284 Reduced 0.48%	58,947 $8.6 Million
Q3 2019 Oct 09, 2019	SELL	$126.95 - $142.14 $1.43 Million - $1.6 Million	-11,279 Reduced 16.0%	59,231 $7.66 Million
Q2 2019 Jul 09, 2019	SELL	$131.15 - $144.24 $1,967 - $2,163	-15 Reduced 0.02%	70,510 $9.82 Million
Q1 2019 May 02, 2019	SELL	$125.72 - $139.79 $182,796 - $203,254	-1,454 Reduced 2.02%	70,525 $9.86 Million
Q4 2018 Jan 31, 2019	BUY	$122.84 - $147.84 $279,583 - $336,483	2,276 Added 3.27%	71,979 $9.29 Million
Q3 2018 Nov 08, 2018	BUY	$121.58 - $142.88 $423,706 - $497,936	3,485 Added 5.26%	69,703 $9.63 Million
Q2 2018 Jul 31, 2018	SELL	$119.4 - $131.76 $1.22 Million - $1.35 Million	-10,242 Reduced 13.4%	66,218 $8.04 Million
Q1 2018 Apr 16, 2018	SELL	$125.1 - $148.14 $325,510 - $385,460	-2,602 Reduced 3.29%	76,460 $9.8 Million
Q4 2017 Feb 05, 2018	SELL	$131.22 - $143.62 $358,755 - $392,657	-2,734 Reduced 3.34%	79,062 $11 Million
Q3 2016 Oct 25, 2017	BUY	N/A	81,796	81,796 $10.6 Million

Others Institutions Holding JNJ

# of Institutions

4,272

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $405B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Crossmark Global Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Crossmark Global Holdings, Inc. with notifications on news.

Account

Crossmark Global Holdings, Inc. Johnson & Johnson Transaction History